Literature DB >> 19858375

If mammalian target of metformin indirectly is mammalian target of rapamycin, then the insulin-like growth factor-1 receptor axis will audit the efficacy of metformin in cancer clinical trials.

Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Sonia Del Barco, Begoña Martin-Castillo, Javier A Menendez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19858375     DOI： 10.1200/JCO.2009.24.5456

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

Review 1.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

2.  Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.

Authors:  Aleksei Viktorovich Novik; Svetlana Anatolievna Protsenko; Irina Alexandrovna Baldueva; Lev Michailovich Berstein; Vladimir Nikolaevich Anisimov; Irina Nikolaevna Zhuk; Anna Igorevna Semenova; Dilorom Khamidovna Latipova; Elena Viktorovna Tkachenko; Tatiana Yurievna Semiglazova
Journal:  Oncologist       Date:  2021-04-09

3.  Associations of insulin resistance and adiponectin with mortality in women with breast cancer.

Authors:  Catherine Duggan; Melinda L Irwin; Liren Xiao; Katherine D Henderson; Ashley Wilder Smith; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash; Anne McTiernan
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

Review 4.  Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

Authors:  Kimberly S Peairs; Bethany B Barone; Claire F Snyder; Hsin-Chieh Yeh; Kelly B Stein; Rachel L Derr; Frederick L Brancati; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

5.  Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.

Authors:  Pei Zhu; Meghan Davis; Amanda J Blackwelder; Nora Bachman; Bolin Liu; Susan Edgerton; Leonard L Williams; Ann D Thor; Xiaohe Yang
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-09

6.  Targeted Therapy of Ewing's Sarcoma.

Authors:  Vivek Subbiah; Pete Anderson
Journal:  Sarcoma       Date:  2010-10-31

Review 7.  Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderly.

Authors:  Vivek Subbiah
Journal:  Curr Oncol Rep       Date:  2014-09       Impact factor: 5.075

8.  Gerosuppressant metformin: less is more.

Authors:  Javier A Menendez; Sílvia Cufí; Cristina Oliveras-Ferraros; Luciano Vellon; Jorge Joven; Alejandro Vazquez-Martin
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

9.  Hormesis does not make sense except in the light of TOR-driven aging.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2011-11       Impact factor: 5.682

10.  Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.

Authors:  Y Storozhuk; S N Hopmans; T Sanli; C Barron; E Tsiani; J-C Cutz; G Pond; J Wright; G Singh; T Tsakiridis
Journal:  Br J Cancer       Date:  2013-04-30       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.